Teens with obesity more likely to develop cancer during midlife
Adolescent obesity is linked to midlife cancer risk among men and women, highlighting the need to tackle obesity early in life, according to findings from a population-based study published in The Lancet Diabetes & Endocrinology.
“Our study indicates that adolescent obesity is a major risk factor for cancer incidence in young and [middle] adulthood,” Gilad Twig, MD, PhD, professor in the research and academic division of the Israel Defense Forces Medical Corps in Ramat Gan, Israel, and colleagues wrote. “Given the global increase of obesity in childhood and adolescence, the cancer burden among young adults is expected to increase.”
Twig and colleagues analyzed medical and socioeconomic data from 2,298,130 adolescents aged 16 to 19 years routinely screened as part of an assessment for medical eligibility for mandatory military service between 1967 and 2012 (928,110 women; mean age at medical evaluation, 17 years). Researchers assessed BMI during adolescence, classified according to CDC percentiles: less than fifth percentile (underweight), fifth through the 49th percentile (low-normal BMI), 50th through the 74th percentile, 75th through the 84th percentile, 85th through the 94th percentile (overweight) and the 95th or greater percentile (obese). Researchers used Cox proportional hazard models to estimate HRs for incident cancer cases using the group with low-normal BMI during adolescence as reference. Primary outcome was any cancer diagnosis between 1967 and 2012, using data from the Israeli National Cancer Registry. The secondary outcome was all-cause mortality among those who developed cancer.
Risk with rising BMI
During 29,542,735 person-years of follow-up for men and 18,044,863 person-years of follow-up for women, researchers observed 26,353 and 29,488 incident cancer cases among men and women, respectively. Mean age at diagnosis was 42 years for men and 40 years for women. The most common cancers were lymphoma (17.4%), melanoma (11.9%) and colorectal cancer (7.7%) among men, and breast (32.7%) and cervical cancer (19.9%) among women.
Adjusted HR for any cancer for men with obesity during adolescence was 1.26 (95% CI, 1.18-1.35), with results persisting after excluding lung cancer. Among women, researchers did not observe an association between obesity during adolescence and overall cancer, due to inverse associations of obesity with cervical and breast cancer.
“We determined unadjusted associations of BMI with cancer-specific incidence and found that BMI was inversely associated with lung cancer in men (6.1% of cancers) and breast and cervical cancers in women (52.6% of cancers),” the researchers wrote. “Therefore, we analyzed cancer incidence in women after excluding cases of these cancers to avoid blunting the effect of obesity during adolescence on cancer risk by these two cancer types.”
In the analyses excluding women with breast or cervical cancers, researchers observed a dose-dependent increase in cancer incidence across BMI groups. Compared with women with low-normal BMI during adolescence, women with obesity during adolescence were 27% more likely to develop cancer (95% CI, 1.13-1.44).
In sensitivity analyses, researchers found that overall cancer risk increased after 10 years for men with overweight during adolescence (HR = 1.14; 95% CI, 1.01-1.29), as well as for women with overweight during adolescence when excluding breast and cervical cancers (HR = 1.22; 95% CI, 1.08-1.39).
Researchers found that the projected population attributable risk percentage for any cancer, using 2017 prevalence data for high BMI, was 5.1% for men (95% CI, 4.2-6.1) and 5.7% for women (95% CI, 4.2-7.3) excluding breast and cervical cancers.
During follow-up, researchers observed 8,351 and 5,218 deaths among men and women, respectively. Compared with men with low-normal BMI during adolescence, 5-year survival rates were lower among men with obesity during adolescence (75.2% vs. 72.2%). Similarly, compared with women with low-normal BMI during adolescence, 5-year survival rates were lower among women with obesity during adolescence (89.3% vs. 83.1%).
The researchers found that having a high BMI during adolescence was associated with increased mortality risk across all cancer groups for both sexes. HRs for all-cause mortality were 1.33 for men with obesity as adolescents (95% CI, 1.18-1.49) and 1.89 for women with obesity during adolescence (95% CI, 1.56-2.28), with results persisting after adjustment for age at study entry, birth year, education and socioeconomic status.
In a related editorial that accompanied the study findings, the journal stated that the association of obesity with cancer, like that of obesity with diabetes and nonalcoholic fatty liver disease, underscores that noncommunicable diseases “do not exist in isolation.”
“Tackling noncommunicable diseases requires bolder action, a consolidated approach, and commitment to eliminate the shared environmental factors and social determinants that drive this burgeoning epidemic,” the authors wrote in the editorial. “Maybe it is time for a unified noncommunicable diseases awareness day.” – by Regina Schaffer
Disclosures: The authors report no relevant financial disclosures.